Centrus Energy Corp. today announced that Daniel B. Poneman, Chief Executive Officer, is scheduled to participate in a panel titled “Building out the Advanced Nuclear Energy Supply Chain” at Guggenheim Securities’ Second Annual Investing in Advanced Nuclear Energy: Meeting Clean Energy Needs Across the Economy Conference in New York City, New York, on Thursday, March 30, 2023.
Bethesda, Md. – Centrus Energy Corp. (NYSE American: LEU) today announced that Philip Strawbridge, Chief Financial Officer, is scheduled to participate in Roth Capital Partners’ 35th Annual Conference on March 12th through 14th in Dana Point, California.
BETHESDA, Md. – Centrus Energy Corp. (NYSE American: LEU) will broadcast its quarterly conference call with shareholders and the financial community over the Internet on Wednesday, February 22, 2023, at 8:30 a.m. ET. The Company will release its fourth quarter and year-end earnings report for 2022, which ended December 31, 2022, after the close of markets on Tuesday, February 21.
Centrus Energy Corp. announced that it has completed construction of a cascade of advanced uranium enrichment centrifuges as well as most of the associated support systems. This milestone puts Centrus on track to begin demonstrating first-of-a-kind production of High-Assay, Low-Enriched Uranium (HALEU) in Piketon, Ohio, by the end of 2023, after completing remaining support systems and obtaining final approval from the Nuclear Regulatory Commission.
Centrus Energy Corp. announced that its wholly-owned subsidiary, American Centrifuge Operating LLC, has signed a definitized contract with the U.S. Department of Energy (DOE) to pioneer production of High-Assay, Low-Enriched Uranium (HALEU) at its facility leased from DOE in Piketon, Ohio.
The U.S. Department of Energy (DOE) today announced an approximately $150 million cost-shared award with American Centrifuge Operating, LLC of Bethesda, Maryland, a subsidiary of Centrus Energy Corp, to demonstrate the nation’s ability to produce high-assay low-enriched uranium (HALEU)—a crucial material needed to develop and deploy advanced reactors in the United States.
“While our third quarter results reflected the typical lumpiness attributable to the timing of customer deliveries that we regularly discuss on earnings calls, we continued to see strong momentum across our business segments, as reflected in both our total order book value and in the broader trends toward greater investment in nuclear energy,” said Centrus President and CEO Daniel B. Poneman. “Congress approved a $700 million investment in High-Assay, Low-Enriched Uranium (HALEU) as part of the U.S. Inflation Reduction Act, and there is growing bipartisan support for further action to jumpstart construction of domestic LEU and HALEU capacity. We look forward to seeing how DOE implements that funding. In the first nine months of 2022, we also secured $270 million in new sales contracts and commitments with contract terms extending through 2030 to support our long-term success. As the only company with a U.S. Nuclear Regulatory Commission license to produce HALEU, as well as the only domestic operator of deployment-ready enrichment technology in the United States, Centrus is well positioned to serve the growing need for critical fuels for advanced nuclear reactors both domestically and around the world.”
BETHESDA, Md. – Centrus Energy Corp. announced that it has secured new nuclear fuel sales contracts and commitments with an estimated value of approximately $320 million in the last 12 months -- including approximately $270 million year-to-date.